Your browser doesn't support javascript.
loading
Integrins as Therapeutic Targets for SARS-CoV-2.
Gressett, Timothy E; Nader, Danielle; Robles, Juan Pablo; Buranda, Tione; Kerrigan, Steven W; Bix, Gregory.
Afiliación
  • Gressett TE; Tulane University School of Medicine, Clinical Neuroscience Research Center (CNRC), New Orleans, LA, United States.
  • Nader D; Department of Neurology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Robles JP; Tulane Brain Institute, Tulane University, New Orleans, LA, United States.
  • Buranda T; RCSI University of Medicine and Health Sciences, School of Pharmacy and Biomolecular Sciences (PBS), Dublin, Ireland.
  • Kerrigan SW; Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Juriquilla, Mexico.
  • Bix G; University of New Mexico Health Sciences Center (HSC), Department of Pathology, Albuquerque, NM, United States.
Front Cell Infect Microbiol ; 12: 892323, 2022.
Article en En | MEDLINE | ID: mdl-35619646
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article